NEUE neuehealth.com: מכפיל P/S עתידי
NeueHealth, Inc. (NEUE) is fighting for survival amidst the aggressive dominance of industry behemoths. The forward P/S ratio reflects the immediate market reaction, with the 0.10 metric serving as the target level. While the company's capital relies on Medicare and insurance services, the business is currently pivoting toward primary care to overcome the aftermath of previous financial difficulties.
%20%D7%9C%D7%9E%D7%9B%D7%99%D7%A8%D7%95%D7%AA%20NeueHealth%2C%20Inc.&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_NEUE_-_NeueHealth-Inc._-_Forward-Price-to-Sales "NEUE: מכפיל P/S עתידי NeueHealth, Inc. 21.02.2024 - 18.10.2025 | 👁️GURU.Markets👁️")
neuehealth.com (NEUE) - פילוחי מדדים ודוחות פיננסיים
The ratio's dynamics depend on management's ability to curb medical inflation to maintain operating margins. This forward P/S valuation metric compares the current market value of NeueHealth, Inc. (NEUE) with expected sales volume, which, given the defensive nature of the insurance business, allows investors to assess the premium paid for stable cash flows by analyzing this chart.
